Med School Graduate Part of NIH Research at Sanford
The grant was awarded as part of the NIH’s Centers of Biomedical Research Excellence, or CoBRE, which supports activity that enhances institutional research capacity. CoBRE also awarded the Cancer Biology Research Center at Sanford Research a nearly $11.5 million grant in 2011 to develop a group of basic science and translational cancer researchers. The most recent award represents Phase II of the project.
“Our hope is that this latest NIH grant allows us to improve cancer care for this region,” said Keith Miskimins, Ph.D., who is the project’s principal investigator and director of the Cancer Biology Research Center at Sanford Research. “A grant this large positions the participating scientists well for long-term sustainability in the research world.”
Four research projects and two core laboratories highlight the grant.
The following researchers and projects will receive funding:
- Steven Powell, M.D., who received his medical degree from USD Sanford School of Medicine, will explore if an immunotherapy drug, pembrolizumab, can help fight head and neck cancer;
- Paola Vermeer, Ph.D., will study how immune cell interactions affect metastasis of cancer tumors and potential immunotherapy options based on biomarkers;
- W. Chad Spanos, M.D., will look at ways to optimize the immune system’s response to head and neck cancer caused by human papilloma virus;
- Samuel Milanovich, M.D., will study the genetic mutations that might be associated with leukemia.
Existing core laboratories led by Kristi Egland, Ph.D., and Alexi Savinov, M.D., Ph.D., will continue to support CoBRE projects. Egland’s Molecular Pathology Core will provide histology and pathology expertise, while Savinov’s Flow Cytometry Core will perform cell phenotyping and characterization and cell sorting and separation protocols. Both laboratories were established in 2011 as part of Phase I.
“Basic research is important because it leads to discoveries that might someday be translated to patients,” said David Pearce, Ph.D., executive vice president of Sanford Research. “Phase II of CoBRE marks a milestone because the findings could soon have real application to cancer patients. The strength of Sanford’s programs in head and neck cancer and pediatric cancer were a differentiator for our organization.”
The NIH, a part of the U.S. Department of Health and Human Services Policy, is the nation’s medical research agency.
You May Also Like
AUSTIN, Texas — South Dakota senior guard Ciara Duffy was one of five Division I women's basketball players selected to the Academic All-America first team selected by the College Sports Information Directors of America (CoSIDA). Duffy earns Academic All-America honors for the third consecutive season.
SIOUX FALLS, S.D. — All five South Dakota starters scored in double-figures and the Coyotes completed perhaps the greatest regular season in Summit League history with a 63-58 win against rival and second-seeded South Dakota State in the tournament championship game Tuesday inside the Denny Sanford PREMIER Center.
VERMILLION, S.D. – Two University of South Dakota faculty members are partnering with the University of Nebraska-Lincoln and Sioux Falls agency Call to Freedom to better understand what sex trafficking survivors think about the services they receive — and to learn what services they find most helpful.